March 12, 2014 9:53 AM
Ryan Reed Bristol Advance
“Bristol was probably the toughest race track for me that I went to last year. I was able to learn a ton and I think having that experience will help us get our first top-10 of the season. I am so excited that Drive to Stop DiabetesSM is going to go get so much exposure this weekend, and I can't thank Lilly Diabetes enough for making that happen.” -Reed
Reed at Bristol Motor Speedway
- Saturday’s race at Bristol Motor Speedway (BMS) marks the second NASCAR Nationwide Series (NNS) start at the track for Roush Fenway Racing’s (RFR) Ryan Reed. In his other start at the .53-mile oval in the fall of 2013, Reed started 27th and finished 26th.
- The No. 16 team will race chassis RK-801 at BMS this weekend. This is a new chassis that the team tested at Nashville in January.
Visit the American Diabetes Association’s Drive to Stop DiabetesSM Midway Display
- Drive to Stop DiabetesSM (D2SD) will host an activation space in the fan midway at BMS. The display area features the No. 16 D2SD racing simulator, diabetes awareness and educational materials as well as various prizes. The display is open March 15 (8:00 a.m. – 1:30 p.m.) and March 16 (8:00 a.m. – 1:00 p.m.).
- Reed will appear for a Q&A at the Drive to Stop DiabetesSM display on Saturday, March 15 from 9:20 – 9:35 a.m.
Recapping Las Vegas
- In his first NNS start at Las Vegas Motor Speedway, Reed qualified 15th and battled a loose race car. The rookie ultimately held his position, and finished the 300-mile race in 15th.
About the American Diabetes Association
The American Diabetes Association is leading the fight to Stop Diabetes and its deadly consequences and fighting for those affected by diabetes. The Association funds research to prevent, cure and manage diabetes; delivers services to hundreds of communities; provides objective and credible information; and gives voice to those denied their rights because of diabetes. Founded in 1940, our mission is to prevent and cure diabetes and to improve the lives of all people affected by diabetes. For more information please call the American Diabetes Association at 1-800-DIABETES (1-800-342-2383) or visit www.diabetes.org. Information from both these sources is available in English and Spanish.
About Lilly Diabetes
Lilly has been a global leader in diabetes care since 1923, when we introduced the world's first commercial insulin. Today we are building upon this heritage by working to meet the diverse needs of people with diabetes and those who care for them. Through research and collaboration, a broad and growing product portfolio and a continued determination to provide real solutions—from medicines to support programs and more—we strive to make life better for all those affected by diabetes around the world. For more information, visit www.lillydiabetes.com